What changed between these versions
A refinement diff. v3 clarifies the terminology for genetic sequencing data to "genome sequence data" in Section 2(2)(C) and expands reporting requirements in Section 3(n)(1) to include revisions based on recent recalls. Additionally, Section 3(n)(4)(A) now explicitly mentions botulism and other contaminants in the context of contamination events, providing greater specificity.
Overview
A handful of small, targeted changes. · v3 refines existing language, clarifies terminology, and slightly expands reporting scope without altering the core policy direction of the bill.
v3 primarily refines the language and scope of reporting requirements related to infant formula safety. It updates the scientific terminology for genetic data submission to "genome sequence data" and mandates that progress reports on infant formula safety and supply include any revisions to recommendations stemming from recent recalls. Furthermore, the bill explicitly includes botulism and other contaminants as specific types of contamination events to be considered in adequacy of supply reports. The fundamental structure and intent of the bill remain consistent with v2.
Modifications
Ensures that the data provided to the Secretary for investigation and corrective action is specified using more precise and current scientific terminology ("whole genome sequence data" instead of "whole genetic sequence"), which can facilitate more accurate and standardized data submission and analysis.
Before
Required manufacturers to provide "the whole genetic sequence" from confirmed positive analytical results of microorganisms.
After
Requires manufacturers to provide "the whole genome sequence data" from confirmed positive analytical results of microorganisms.
Mandates that the Secretary's progress report on infant formula safety and supply strategies must be dynamic, incorporating lessons learned and necessary adjustments based on actual recall events, thereby ensuring the strategy remains relevant and responsive to ongoing safety challenges.
Before
Required the Secretary to issue a progress report on implementing recommendations to improve infant formula safety and supply, including additional authorities or resources needed.
After
Expands the progress report requirement to also include any revisions to the recommendations as a result of infant formula recalls since the publication of the initial report.
Directs the Secretary and stakeholders to specifically consider serious contaminants like botulism when developing practices for infant formula safety and supply, potentially leading to more targeted and robust preventative and response measures for these specific threats.
Before
Required engagement with stakeholders to determine evidence-based practices for maximizing infant formula supply and safety, including identifying contamination events and the impact of corrective actions.
After
Specifies that the contamination events to be considered in determining evidence-based practices explicitly include "events associated with botulism or other contaminants."